Jane Wasman
2018
Compensation breakdown
Non-Equity Incentive Plan | $863,543 |
---|---|
Salary | $570,900 |
Other | $8,250 |
Total | $1,442,693 |
Wasman received $863.5K in non-equity incentive plan, accounting for 60% of the total pay in 2018.
Wasman also received $570.9K in salary and $8.3K in other compensation.
Rankings
In 2018, Jane Wasman's compensation ranked 7,351st out of 14,244 executives tracked by ExecPay. In other words, Wasman earned more than 48.4% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 7,351 | 48th |
Manufacturing | 2,852 | 51st |
Chemicals And Allied Products | 1,074 | 50th |
Drugs | 908 | 50th |
Biological Products, Except Diagnostic Substances | 168 | 50th |
Pay ratio
Jane Wasman's Pay | $1,442,693 |
---|---|
Median Employee's Pay | $202,725 |
Pay Ratio | 7to 1 |
In 2018, the annual total compensation of Jane Wasman was $1,442,693.
The annual total compensation of the median employee at Acorda Therapeutics was $202,725.
The ratio of Jane Wasman's pay to the pay of median employee was therefore 7 to one.
Wasman's colleagues
We found five more compensation records of executives who worked with Jane Wasman at Acorda Therapeutics in 2018.
2018
Ron Cohen
Acorda Therapeutics
Chief Executive Officer
2018
Burkhard Blank
Acorda Therapeutics
Chief Medical Officer
2018
Andrew Hindman
Acorda Therapeutics
Chief Business Officer
2018
Lauren Sabella
Acorda Therapeutics
Chief Commercial Officer
2018
David Lawrence
Acorda Therapeutics